„Customization of the insulin therapy in patient“: a case report


Authors: Zbynek Schroner
Authors‘ workplace: Schroner MED s. r. o., interná a diabetologická ambulancia, Košice
Published in: Forum Diab 2013; 2(2): 122-124
Category:

Overview

Current opinion of the American Diabetes Association and the European Association for the Study of Diabetes (ADA / EASD) recommends personalized approach in treatment reflecting the needs, preferences and tolerances of each patient, thus individualization of therapy. The management of 81-years old polymorbid patient with diabetes mellitus type 2 in this case report confirms the therapeutic tendency. Thus in this case, the use of premixed insulin analogues.

Key words:
diabetes mellitus type 2 – intensified insulin regimen – insulin lispro mix – premixed insulin analogues


Sources

1. Donner T, Muňoz M. Update on insulin therapy for type 2 diabetes. J Clin Endocrinol Metab 2012; 97(5): 1405–1413.

2. Hirsch IB. Insulin analogues. N Engl J Med, 2005, 352(2): 174–183.

3. Inzuchci SE, Bergenstal RM, Buse JB et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2012; 55(6): 1577–1596.

4. Schroner Z. Súčasnosť a perspektívy inzulínovej liečby. Interná Med 2007; 7(1): 7–15.

5. Uličiansky V, Schroner Z. Čo prináša najnovšie stanovisko (Position Statement) Americkej diabetologickej asociácie (ADA) a Európskej asociácie pre štúdium diabetu (EASD) pre klinickú prax? Interná Med 2012; 4(12): 154–161.

Labels
Diabetology Endocrinology Internal medicine
Login
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account